Insights

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Hiring and retaining technical talent: How to build an A+ team

Hiring and retaining technical talent: How to build an A+ team

October 23, 2024

Embracing biological complexity: our investment in Passkey Therapeutics

Embracing biological complexity: our investment in Passkey Therapeutics

October 22, 2024

From blueprints to bots: AI and agentic systems for architecture, engineering and construction (AEC)

From blueprints to bots: AI and agentic systems for architecture, engineering and construction (AEC)

October 21, 2024

All applications are becoming distributed systems

All applications are becoming distributed systems

October 9, 2024

Building Skylo: Parth Trivedi’s lessons in scaling a global network

Building Skylo: Parth Trivedi’s lessons in scaling a global network

October 2, 2024

Using AI to bring clarity and precision to private market investing: Our investment in Tetrix

Using AI to bring clarity and precision to private market investing: Our investment in Tetrix

September 26, 2024

From Series A to Salesforce: Celebrating Own

From Series A to Salesforce: Celebrating Own

September 6, 2024

The enterprise decision-making engine

The enterprise decision-making engine

August 20, 2024

Breakthrough advancements in understanding climate risk: our investment in First Street

Breakthrough advancements in understanding climate risk: our investment in First Street

July 25, 2024

Celebrating a decade of curiosity

Celebrating a decade of curiosity

July 16, 2024

Non-destructive editing in design tools

Non-destructive editing in design tools

July 12, 2024

Team growth and promotions

Innovation Endeavors growth and team promotions

July 9, 2024

Rich Stern on embracing failure: Lessons from the CEO of TuneIn

Rich Stern on embracing failure: Lessons from the CEO of TuneIn

June 27, 2024

A leap in genomic medicine: why we invested in Exsilio Therapeutics

A leap in genomic medicine: why we invested in Exsilio Therapeutics

June 25, 2024

Building for the real world

Building for the real world

June 24, 2024